Osteoporosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Female sex; 2. Age 65 years or older; 3. Willing to participate in the study.
Exclusion criteria
Exclusion criteria: 1. Actual use of bisfosfonates, strontium ranelate, raloxifene or teriparatide or use during the previous two years; 2. Actual daily use of corticosteroids of 7.5 mg prednisolonequivalent or more; 3. Terminal illness; 4. Unable to participate according to general practitioner; 5. Body weight is 135 kg or more.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to new fracture and number of fractures after 36 months in patients with high fracture risk according to FRAX assessment. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Time to new fracture; 2. Number of fractures after 36 months; 3. Medical cost; 4. Death rate; 5. Falls. | — |
Contacts
vd Boechhorststraat 7